Nanotherapeutics Drug Delivery Concepts in Nanoscience

Exploring the use of nanoparticle drug delivery systems allowing for innovative therapeutic approaches, this timely volume provides an overview of possible therapeutic applications. The first part of the book highlights general properties of and phenomena observed with nanoparticles and the subsequent consequences for applications in drug delivery. The second part focuses on the therapeutic approaches that are possible through the use of nanoparticles, with each chapter discussing a specific disease--diabetes, cancer, inflammation--and the relevant therapeutic approaches based on the design of nanoparticulate drug delivery systems. Written in a concise manner, the guide offers insight into the basics of nanoparticle preparation as well as a more detailed account of what is therapeutically feasible by using nanoparticle approaches.

This timely book provides an overview of possible therapeutic applications. The first part of the book highlights general properties of and phenomena observed with nanoparticles, and the subsequent consequences for applications in drug delivery. The second part focuses on the therapeutic approaches that are possible through the use of nanoparticles, with each chapter discussing a specific disease (e.g., diabetes, cancer, inflammation) and the relevant therapeutic approaches based on the design of nanoparticulate drug delivery systems. From this concise book, readers will gain an insight into the basics of nanoparticle preparation and find a more detailed account of what is therapeutically feasible by using nanoparticle approaches.

General Aspects in Nanoparticulate Drug Delivery: NanoparticlesTransport Phenomena on Biological BarriersDrug Targeting ApproachesGene TherapyTherapeutic Approaches for Various Diseases: CancerImmunologic ApproachesInflammatory DiseasesDiabetesBrain DiseasesSkin DiseasesAntibioticsParasitologyVaccination

Alf Lamprecht studied pharmacy at the Saarland University in Saarbrucken, Germany, where he also received his PhD in 2001. After postdoctoral fellowships at the University of Angers, France, and the Gifu Pharmaceutical University, Japan, he was appointed assistant professor at the University of Nancy, France, before he became professor of pharmaceutical engineering at the University of Franche-Comté in Besancon, France, in 2005. He is a member of the Controlled Release Society (CRS), the American Association of Pharmaceutical Sciences (AAPS), the German Pharmaceutical Society (DPhG) and Academy of Pharmaceutical Science and Technology, Japan (APSTJ). He serves as a member of the editorial board of Drug Development and Industrial Pharmacy. He received the Carl Wilhelm Scheele Prize of the German Pharmaceutical Society (DPhG) in 2001 and the Krka Award (Slovenia) and Eduard-Martin Award (Germany) in 2002.